Controlled Substances Act Clarification in Sciences Act of 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Summary
The bill adds new, science‑based definitions to the Controlled Substances Act and tells the Attorney General to rely on the Health Secretary’s evaluation when placing drugs in schedules. It aims to keep harmful substances controlled while preserving access for legitimate medical and research uses. This could change how drugs are classified and affect patients, doctors, researchers, and law‑enforcement.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Track this bill
Get real-time alerts when HR 9186 changes status, plus AI-powered summaries and stage predictions.
Sign up free